Ceretrieve
PrivateLast Round
Seed
Jan 5, 2021
Total Funding Raised
$1.5M
Company Overview
Ceretrieve is a medical device company that develops neurointerventional devices intended to treat ischemic stroke.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ceretrieve Comparables
Compare Ceretrieve with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RapidPulse | 90% | |
| MIVI Neuroscience | 87% | |
| Perfuze | 86% | |
Ceretrieve Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 5, 2021 |
Key People
Founding team and executive leadership
Ceretrieve Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Seed |
| The Trendlines Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 17, 2026
Grew 31% QoQ, from 13 to 17 employees.
- Oct 16, 2025
Grew 27% QoQ, from 11 to 14 employees.
Ceretrieve Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ceretrieve's valuation, stock price, and market status.